Solonase 1.5MIU Injection
Marketer
Lee Chem Biotech Pvt Ltd
Salt Composition
Streptokinase (1.5Million IU)
Overview Solonase 1.5MIU Injection
Thrombolytic agent Solonase, administered as a 1.5 MIU injection, dissolves dangerous blood clots obstructing blood vessels. It's indicated for patients recovering from myocardial infarction and is also employed in treating pulmonary embolism and ischemic stroke. Administration requires strict medical oversight; dosage and treatment length are determined by your physician, who will closely monitor your progress until stabilization. Potential side effects include injection site hemorrhage, nausea, hypersensitivity reactions, and hypotension, with an increased risk of bleeding. Your doctor will discuss the associated benefits and risks prior to treatment. Continued use of all other prescribed medications for your ongoing health management is crucial. Caution is warranted in patients with bleeding disorders, renal or hepatic impairment; pregnancy, breastfeeding, and all concurrent medications must be disclosed to your physician.
Uses of Solonase 1.5MIU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Solonase 1.5MIU Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Solonase 1.5MIU Injection:
- Allergic reaction
- Nausea
- Injection site bleeding
- Decrease in blood pressure
How to use Solonase 1.5MIU Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
How Solonase 1.5MIU Injection works:
Solonase 1.5MIU Injection breaks down dangerous blood clots within blood vessels, re-establishing blood circulation to compromised tissues. This action averts tissue necrosis and leads to improved patient results.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Solonase 1.5MIU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Solonase 1.5MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Solonase 1.5MIU Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingNOT RELEVANT
Solonase 1.5 MIU Injection is exclusively administered to hospitalized individuals.
KidneySAFE IF PRESCRIBED
The use of Solonase 1.5MIU Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate that dose modification may be unnecessary for these patients; however, medical advice is crucial. Solonase 1.5MIU Injection is contraindicated for those with severe kidney disease.
LiverCAUTION
Administering Solonase 1.5 MIU Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Solonase 1.5 MIU Injection might be necessary. Physician consultation is advised.
What if you forget to take Solonase 1.5MIU Injection :
Should you forget a scheduled Solonase 1.5MIU Injection, seek advice from your physician.
Facts to Know About Solonase 1.5MIU Injection
| Label | Value |
|---|---|
| Chemical Category | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Category | Early Thrombolytic Agents |
3,018 People bought this recently